Michael T. McCaul sold Bristol-Myers Squibb Company (NYSE: BMY)
Michael T. McCaul (R-TX), a U.S. Representative, has disclosed 25 trades in Bristol-Myers Squibb Company (BMY) since 2014, 15 purchases and 10 sales, worth an estimated $1.3M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Michael T. McCaul sold $1,001 - $15,000 of Bristol-Myers Squibb Company (NYSE: BMY) on August 30, 2016. Since that trade, BMY is up +55.05% against the S&P 500 up +291.83%, an outperformance of -236.78%.
Across these filings, Michael T. McCaul has been a net buyer of BMY (a buy-to-sell ratio of 1.50). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Michael T. McCaul's BMY trades vs the price
BMY is up +55.05% since Michael T. McCaul sold on August 30, 2016, versus +291.83% for the S&P 500.
Performance since this trade
All Michael T. McCaul BMY trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Michael T. McCaul & BMY trading FAQ
Is it legal for Michael T. McCaul to trade Bristol-Myers Squibb Company (BMY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Bristol-Myers Squibb Company (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Michael T. McCaul sell BMY?
Michael T. McCaul disclosed a sale of $1,001 - $15,000 of Bristol-Myers Squibb Company (BMY) on August 30, 2016, according to public STOCK Act filings.
How has BMY performed since Michael T. McCaul's trade?
Since Michael T. McCaul sold BMY on August 30, 2016, the stock is up +55.05%, versus +291.83% for the S&P 500 over the same period, an outperformance of -236.78%.
How many times has Michael T. McCaul traded BMY?
Michael T. McCaul has disclosed 25 BMY trades since 2014 (15 purchases and 10 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMY trades?
Quantellect tracks every disclosed congressional trade in Bristol-Myers Squibb Company (BMY) on the Bristol-Myers Squibb Company congressional trading page, which aggregates filings across all members of Congress.
Michael T. McCaul's BMY tradesAll congressional filings for Bristol-Myers Squibb CompanyMichael T. McCaul's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.